Taking everything into account, OMER scores 0 out of 10 in our fundamental rating. OMER was compared to 191 industry peers in the Pharmaceuticals industry. OMER has a bad profitability rating. Also its financial health evaluation is rather negative. OMER is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year OMER has reported negative net income.
OMER had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OMER reported negative net income in multiple years.
OMER had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -65.24%, OMER is not doing good in the industry: 68.59% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-65.24%
ROE	N/A
ROIC	N/A

ROA(3y)-26.61%

ROA(5y)-21.96%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for OMER so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OMER has less shares outstanding than it did 1 year ago.
OMER has more shares outstanding than it did 5 years ago.
OMER has a worse debt/assets ratio than last year.

2.2 Solvency

OMER has an Altman-Z score of -8.62. This is a bad value and indicates that OMER is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of OMER (-8.62) is worse than 70.16% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-8.62

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.89 indicates that OMER may have some problems paying its short term obligations.
OMER has a worse Current ratio (0.89) than 86.39% of its industry peers.
OMER has a Quick Ratio of 0.89. This is a bad value and indicates that OMER is not financially healthy enough and could expect problems in meeting its short term obligations.
OMER has a worse Quick ratio (0.89) than 79.58% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.89
Quick Ratio	0.89

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.55% over the past year.

EPS 1Y (TTM)12.55%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%16.07%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

OMER is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.37% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y25.5%

EPS Next 2Y41.75%

EPS Next 3Y28.5%

EPS Next 5Y29.37%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

OMER reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
OMER is valuated quite expensively with a Price/Forward Earnings ratio of 477.39.
OMER's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. OMER is cheaper than 66.49% of the companies in the same industry.
OMER is valuated expensively when we compare the Price/Forward Earnings ratio to 24.26, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	477.39

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates OMER does not grow enough to justify the current Price/Earnings ratio.
OMER's earnings are expected to grow with 28.50% in the coming years. This may justify a more expensive valuation.